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A purinergic receptor was identified in human myometrium membranes using 5’-~-[3H]ethylcarboxamide- 
adenosine ([3H]NECA) as radioligand. Scatchard analysis of the binding data gave a Kd of 123 nM with 
2.3 pmol ligand bound/mg protein. Displacement studies indicated that the binding site had the 
characteristics of the AZ adenosine receptors and some of those of the P2 purinoceptors since it was 
inhibited by two slowly degradable ATP derivatives with Z&O values comparable to that of NECA. The 
receptor was solubilized with sodium cholate and its binding properties were the same as those of the 
membrane-bound form. No -SH group appeared to be essential for the binding activity. By density 
gradient centrifugation the purinergic receptor-detergent complex was estimated to have an apparent 
molecular mass of 95 kDa. 
Purinergic receptor 5’-N-Ethylcarboxamideadenosine 
Receptor solubilization 
Human uterus membrane 
1. INTRODUCTION been solubilized from bovine forebrain and rat 
brain stem [4,5]. 
Adenosine exerts many physiological effects on 
a variety of tissues through modulation of the 
adenylate cyclase system [ 11. Two distict classes of 
membrane adenosine receptors have been described 
[2,3]: Ri or Al sites responsible for the inhibition 
of adenylate cyclase and Ra or AZ sites which 
mediate an increase in CAMP level. A high affinity 
towards adenosine analogs characterizes the in- 
hibitory receptors at which L-PIA and CHA are 
more potent than 2-chloroadenosine and NECA. 
The stimulatory receptors are low-affinity adeno- 
sine receptors at which NECA is more potent than 
2-chloroadenosine and much more potent than L- 
PIA and CHA. AI receptors have been extensively 
studied in crude membrane prep~ations and have 
The availability of a radioligand preferentially 
effective on AZ receptors such as NECA and the 
observation during a screening study on purinergic 
receptors in different tissues that human myo- 
metrium contained a large number of NECA- 
binding sites prompted us to characterize these 
receptors. We report here the solubilization and 
some properties of the urinergic receptors in 
human uterus.’ 
2. MATERIALS AND METHODS 
Abbreviations: L-PIA, L-N6-phenylisopropyladenosine; 
CHA, N6-cyclohexyladenosine; NECA, S-N-ethylcar- 
boxamideadenosine; NEM, N-ethylmaleimide; p-CMPS, 
~-chloromercuriphenylsulfonic acid 
2,8-13H]CHA (11.5 Ci/mmol) and 2,8-[3H]NECA 
(30.0 Ci/mmol) were obtained from New England 
Nuclear, Fiorence, Italy. Unlabeled NECA was a 
generous gift from Byk Gulden Lomberg, Kon- 
stanz, FRG. Other adenosine derivatives were from 
Sigma, St. Louis, MO. All other chemicals were of 
analytical grade. 
Myometrial samples were collected from pre- 
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menopausal women undergoing hysterectomy and 
were stored at -70°C until use. Crude membrane 
fractions were prepared as in [6]. The washed pel- 
let was resuspended in incubation buffer [50 mM 
Tris-HCl (pH 7.4), 5 mM MgClz, 1 mM dithio- 
threitol] with 2 units/ml of adenosine deaminase at 
37°C for 30min to remove contaminating adeno- 
sine. 
Protein was determined as in [7] using bovine 
serum albumin as standard. 
The binding assay was performed in a final 
volume of 800~1 containing 300-6OOpg protein, 
incubation buffer and [3H]NECA for 45 min at 
4°C. The reaction was terminated by centrifuga- 
tion at 13 000 x g for 30 min at 4°C. The resulting 
pellet was carefully rinsed 3 times with 0.5 ml ice- 
cold 50 mM Tris-HCl (pH 7.4) and incubated with 
150~1 Protosol (NEN) for 40 min at 45°C to allow 
for solubilization. Samples were counted in a 
Beckman LS 1800 scintillation counter at about 
40% efficiency. 
For solubilization of the receptor the membrane 
pellet was suspended in incubation buffer con- 
taining protease inhibitors and 1% Na cholate, 
stirred for 30min at 0°C and then centrifuged at 
105 000 x g for 30 min at 4°C. The resulting super- 
natant was referred to as the solubilized prepara- 
tion. Incubation of the solubilized fraction was 
carried out for 90 min at 4”C, then 0.2 ml bovine 
y-globulin (13 mg/ml) and 0.4 ml polyethylene gly- 
co1 6000 were added and the mixture was im- 
mediately centrifuged as above. 
Specific binding was calculated from the total 
binding minus non-specific binding measured in 
the presence of 250pM unlabeled NECA. 
3. RESULTS 
[‘HI NECA at a concentration (100 nM) compar- 
able to its Kd value was found to bind to mem- 
branes from rat brain (1790 + 350 fmol/mg pro- 
tein), bovine cortex (910 it 275 fmol/mg protein), 
rat muscle (38 f 12 fmol/mg protein), bovine heart 
atrium (193 + 61 fmol/mg protein) and septum 
(41 + 14 fmol/mg protein), and human uterus 
(1278 + 259 fmol/mg protein). When [3H]CHA, a 
selective ligand for Ai receptors, was used at a con- 
centration (4 nM) 4-times its & value, no binding 
was observed in the same membrane preparations, 
except for rat brain (209 + 45 fmol/mg protein). 
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A typical binding curve of [3H]NECA to myo- 
metrial membranes i  shown in fig. 1A. A Scatchard 
plot of the data gave a Kd value of 123 nM and a 
B max of 2.3 pmol/mg protein. [3H]NECA specific 
binding increased linearly with protein concentra- 
tion up to 8OOpg per assay. 
Similar kinetic analysis of [3H]NECA binding 
was performed for the solubilized preparations 
(fig.lB): the Kd value was 144nM in good agree- 
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Fig.1. Specific binding of [3H]NECA to human myo- 
metrium membranes (A) and solubilized preparations 
(B). The representative experiment, performed in tripli- 
cate as described in section 2, was repeated 3 times. 
(Inset) Scatchard analysis of the binding data. 
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ment with the value obtained for the membrane- 
bound sites. The B,,, value was 6.2 pmol/mg pro- 
tein. Since lo-35% of the membrane proteins were 
solubilized by cholate the total recovery of binding 
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Fig.2. Displacement of membrane-bound (A) and solubi- 
lized (B) [3H]NECA specific binding by adenosine deriva- 
tives. Data are the mean of 3 independent experiments 
performed in triplicate as described in section 2 in the 
presence of 10 nM [3H]NECA. The IGO values for ,&, y- 
methylene ATP (A), a,,&methylene ATP (A), 2-chloro- 
adenosine (0), 3’-isobutyl-1-methylxanthine (o), and L- 
PIA(v)were6.7 x lo-‘,3.1 x 10s6,4 x 10e6, 1.1 x 10e4 
and 2.4 x low4 M, respectively, at the membrane-bound 
sites and 3.4 x lo-‘, 6.0 x 10m6, 6.5 x 10W6, 1.2 x low4 
and 4.5 x 10e4 M, respectively, at the solubilized sites. 
The KS0 value for NECA (0) reported for the 
membrane-bound sites was 1.9 x lo-‘M. 
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sites in the solubilized form ranged from 40 to 
100%. 
To verify whether the characteristics of the 
membrane-bound and soluble [ 3H] NECA receptor 
were essentially similar a series of adenosine de- 
rivatives were examined for their ability to inhibit 
[3H]NECA specific binding (fig.2A,B). 
Myometrium membranes were kept frozen at 
-20°C for 1 week and at -70°C for 15 days 
without loss of [3H]NECA binding activity. Ex- 
posure to a temperature of 65°C for 2 h almost 
completely abolished the membrane specific bind- 
ing and preincubation with trypsin (lOOpg/ml) for 
3 h at 4°C decreased it by 75%. Pretreatment with 
3 mM NEM or 1 mM p-CMPS had no effect. As 
far as the solubilized binding sites were concerned 
they were stable only for 1 day at 4°C. Storage for 
5 days at -20°C led to a 70% loss in binding ability 
and brief exposure to heat (15 min at 37°C) reduc- 
ed it by about 80%. NEM and p-CMPS were also 
without effect on the solubilized form. 
Density gradient centrifugation of the solubi- 
lized produced a single peak of [ 3H] NECA binding 
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Fig.3. Sucrose gradient centrifugation of the solubilized 
preparation from myometrium membranes. Aliquots 
(0.2 ml) were layered on 5-ml, 5-20% sucrose gradients 
made in incubation buffer plus 0.5% Na cholate and 
centrifuged at 105 000 x g for 18 h at 4°C. Fractions of 
about 220~1 were collected and assayed for specific 
[3H]NECA binding. Beef liver catalase (C), hog muscle 
lactic dehydrogenase (LDH), and beef blood hemoglobin 
(Hb) were run in parallel as standards. 
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activity corresponding to an apparent molecular 
mass of 95 f 10 kDa (fig.3). 
4. DISCUSSION 
We have demonstrated in human myometrium 
the existence of a large number of binding sites 
with the characteristics of a purinergic receptor. 
The affinity constant for [3H]NECA and the order 
of potency of adenosine analogs in displacing 
[3H]NECA specific binding conform to the low- 
affinity, adenylate cyclase stimulatory adenosine 
receptors (A2 or Ra) as defined in [2]. The sites do 
not show the characteristics of the Ar (or Ri) in- 
hibitory adenosine receptors when tested with 
[3H]CHA, a more selective ligand for these recep- 
tors. cu,p- and ,&, y-methylene ATP, two ATP de- 
rivatives which we observed to be only slightly 
metabolized under our experimental conditions, 
were able to displace [3H]NECA with ZCso values 
comparable to that of NECA, indicating that the 
myometrial binding sites also possess ome charac- 
teristics of PZ purinoceptors according to the 
classification in [8]. 
Adenyl compounds were shown to induce both 
contraction and relaxation of the uterus and the 
existence of two distinct adenosine receptors was 
hypothesized in this tissue [9]. Our observations 
that a high receptor recovery was obtained upon 
solubilization, that the binding properties are the 
same as in the membrane-bound form, and that a 
single peak with binding capacity results from den- 
sity sedimentation of the solubilized extract sug- 
gest the existence of a single membrane-bound 
receptor. 
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